Why Amarin Stock Is Jumping Today

Shares of Amarin (NASDAQ: AMRN) jumped by as much as 11.7% in pre-market trading Monday morning. What's driving this sizable move higher ahead of the opening bell?

On Friday, Amarin announced that the Food and Drug Administration had approved Vascepa as an add-on to statin therapy in patients with elevated triglyceride levels who either have established cardiovascular disease or diabetes mellitus with two additional risk factors for cardiovascular disease. 

Image Source: Getty Images.

Continue reading

Source Fool.com